A combined approach to early detect in vitro drug-induced hemostatic changes in preclinical safety
- 1 June 2017
- journal article
- Published by Elsevier in Experimental and Toxicologic Pathology
- Vol. 69 (5), 275-283
- https://doi.org/10.1016/j.etp.2017.01.010
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Optimization of Multiplate® whole blood platelet aggregometry in the Beagle dog and Wistar rat for ex vivo drug toxicity testingExperimental and Toxicologic Pathology, 2013
- Identification of Fibrin Clot-Bound Plasma ProteinsPLOS ONE, 2012
- Evaluation of multiple electrode aggregometry in whole blood using Multiplate® Mini Test cellsThrombosis Research, 2012
- SERCA2b Activity Is Regulated by Cyclophilins in Human PlateletsArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Effects of Immunosuppressive Drugs on Platelet Aggregation and Soluble P-Selectin Levels in Renal Transplant PatientsRenal Failure, 2009
- Urine Metabolites Reflect Time-Dependent Effects of Cyclosporine and Sirolimus on Rat Kidney FunctionChemical Research in Toxicology, 2008
- Drug-Induced Thrombosis—Experimental, Clinical, and Mechanistic ConsiderationsToxicologic Pathology, 2007
- A Comparison of Reported Gastrointestinal and Thromboembolic Events Between Rofecoxib and Celecoxib Using Observational DataDrug Safety, 2005
- CyclosporinDrugs, 2001
- Original Article: Cyclosporine a and FK 506 Affect Platelet Functions in VitroPlatelets, 1995